TrialBritish journal of clinical pharmacology2018

Topical administration of regorafenib eye drops: phase I dose-escalation study in healthy volunteers.

Torsten Zimmermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.